Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 191,458 | 228,363 | 251,510 | 278,839 | 264,493 |
| Marketable Securities | 527,882 | 561,969 | 494,450 | 494,871 | 358,560 |
| Receivables | 18,739 | 23,312 | 106,446 | 34,174 | 226,396 |
| Inventories | 10,006 | 11,458 | 11,545 | 13,511 | 10,240 |
| Other current assets | 0 | 0 | 87,510 | 107,663 | 0 |
| TOTAL | $771,098 | $850,816 | $978,276 | $974,590 | $919,512 |
| Non-Current Assets | |||||
| PPE Net | 38,133 | 42,149 | 44,800 | 49,120 | 129,643 |
| Intangibles | 112,542 | 112,888 | 113,462 | 113,080 | 112,958 |
| Other Non-Current Assets | 33,802 | 37,309 | 39,974 | 43,099 | 174,436 |
| TOTAL | $184,477 | $192,346 | $198,236 | $205,299 | $417,037 |
| Total Assets | $955,575 | $1,043,162 | $1,176,512 | $1,179,889 | $1,336,549 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 22,936 | 16,101 | 24,578 | 15,227 | 50,595 |
| Accrued Expenses | 81,424 | 103,027 | 107,165 | 115,586 | 86,697 |
| Other current liabilities | 135,527 | 132,449 | 185,647 | 189,769 | 132,531 |
| TOTAL | $330,574 | $342,461 | $459,950 | $429,869 | $389,138 |
| Non-Current Liabilities | |||||
| Long Term Debt | 291,490 | 291,039 | 244,213 | N/A | N/A |
| Deferred Revenues | 86,577 | 88,772 | 140,053 | 104,251 | 113,763 |
| Other Non-Current Liabilities | 165,744 | 193,244 | 239,068 | 507,318 | 458,153 |
| TOTAL | $815,708 | $845,463 | $844,315 | $906,692 | $909,786 |
| Total Liabilities | $1,146,282 | $1,187,924 | $1,304,265 | $1,336,561 | $1,298,924 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 164,946 | 164,438 | 162,936 | 162,499 | 162,422 |
| Common Shares | 1,682 | 1,678 | 1,650 | 1,648 | 1,645 |
| Retained earnings | -4,631,026 | -4,577,639 | -4,568,148 | -4,585,675 | -4,383,296 |
| Other shareholders' equity | -7,820 | -5,393 | 1,989 | -1,408 | -917 |
| TOTAL | $-190,707 | $-144,762 | $-127,753 | $-156,672 | $37,625 |
| Total Liabilities And Equity | $955,575 | $1,043,162 | $1,176,512 | $1,179,889 | $1,336,549 |